Supplementary Tables 2-13 from Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table 2: BT-TR1 versus BT474 RNA sequencing normalized gene expression Supplementary Table 3: BT-TR2 versus BT474 RNA sequencing normalized gene expression Supplementary Table 4: BT-TPR1 versus BT474 RNA sequencing normalized gene expression Supplementary Table 5: BT-TPR2 versus BT474 RNA sequencing normalized gene expression Supplementary Table 6: BT-TR1 versus BT474 positively enriched hallmark pathways. Supplementary Table 7: BT-TR2 versus BT474 positively enriched hallmark pathways. Supplementary Table 8: BT-TPR1 versus BT474 positively enriched hallmark pathways. Supplementary Table 9: BT-TPR2 versus BT474 positively enriched hallmark pathways. Supplementary Table 10: BT-TR1 versus BT474 negatively enriched hallmark pathways. Supplementary Table 11: BT-TR2 versus BT474 negatively enriched hallmark pathways. Supplementary Table 12: BT-TPR1 versus BT474 negatively enriched hallmark pathways. Supplementary Table 13: BT-TPR2 versus BT474 negatively enriched hallmark pathways.
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361877542